13F Holdings
中文EN

ESTA ESTABLISHMENT LABS HOLDINGS INC.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1688757 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY38.3%
TTM net income YoY53.7%
TTM EPS YoY55.3%
Revenue 3-yr CAGR14.2%
Net income 3-yr CAGR—

Margins

Gross margin70.2%
Operating margin-6.6%
Net margin-14.6%
FCF margin-8.2%
EBITDA margin—

Returns

ROE-240.7%
ROA-11.0%
ROIC (approx.)-6.7%
Asset turnover0.76x

Leverage & solvency

Liabilities / assets95.7%
Debt / equity17.17x
Current ratio3.57x
Interest coverage-0.62x

Cash quality & payout

Operating cash flow / net income0.35x
Accruals ratio-7.2%
Payout ratio—
Capex / revenue3.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$211.08M$166.03M$165.15M$161.70M$126.68M
Cost of revenue$64.77M$56.50M$58.17M$55.10M$41.28M
Gross profit$146.31M$109.53M$106.98M$106.59M$85.40M
R&D expense$20.25M$19.71M$26.43M$20.27M$18.32M
SG&A expense$165.07M$139.81M$145.57M$125.98M$92.23M
Operating income-$39.01M-$49.99M-$65.03M-$39.66M-$25.14M
Interest expense$25.26M$20.83M$15.39M$11.76M$9.06M
Pretax income-$58.02M-$84.63M-$78.58M-$72.82M-$39.71M
Income tax-$6.96M-$32,000-$81,000$2.38M$1.43M
Net income-$51.06M-$84.60M-$78.50M-$75.21M-$41.14M
EBITDA-$32.81M-$45.29M-$62.23M-$37.16M-$22.64M
EPS (basic)-1.72-3.00-3.07-3.08-1.72
EPS (diluted)-1.72-3.00-3.07-3.08-1.72
Weighted avg. shares (diluted)29.62M28.16M25.60M24.46M23.97M
Balance sheet
Cash & equivalents$75.57M$90.35M$40.03M$66.36M$53.41M
Receivables$77.50M$65.00M$46.92M$35.42M$24.44M
Inventory$85.61M$78.77M$79.47M$36.58M$28.41M
Current assets$249.94M$243.04M$174.90M$149.90M$113.27M
PP&E, net$75.61M$78.03M$77.20M$51.09M$18.66M
Goodwill$1.21M$1.21M$465,000$465,000$465,000
Intangibles$9.94M$11.68M$7.99M$4.61M$4.37M
Total assets$357.17M$346.83M$268.64M$211.06M$139.53M
Current liabilities$82.14M$68.28M$57.15M$38.96M$31.89M
Short-term debt—$0———
Long-term debt$247.52M$219.58M$188.74M$175.46M$51.91M
Total debt$247.52M$219.58M$188.74M$175.46M$51.91M
Total liabilities$333.62M$293.74M$250.25M$219.25M$88.79M
Shareholders' equity$23.55M$53.09M$18.39M-$8.19M$50.74M
Net debt$171.95M$129.23M$148.70M$109.11M-$1.51M
Shares outstanding29.30M28.79M26.09M24.41M24.08M
Cash flow statement
Operating cash flow-$50.89M-$58.52M-$88.51M-$52.17M-$27.53M
Capital expenditure$6.05M$6.11M$7.91M$2.85M$2.42M
Free cash flow-$56.94M-$64.63M-$96.42M-$55.02M-$29.96M
Investing cash flow-$7.03M-$15.61M-$24.55M-$34.79M-$7.16M
Financing cash flow$40.43M$125.89M$86.23M$100.25M$4.05M
Depreciation & amortization$6.20M$4.70M$2.80M$2.50M$2.50M
Stock-based compensation$11.41M$14.40M$14.36M$13.36M$10.41M

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.